- Australia approves first drug for treatment of Alzheimer’s disease NST Online
- Australia approves new drug to treat early Alzheimer’s disease The Guardian
- Donanemab approved in Australia for treatment of Alzheimer’s disease Australian Broadcasting Corporation
- Lilly’s Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer’s disease Eli Lilly
- $4700-a-month treatment to slow Alzheimer’s disease gets TGA tick AusDoc
